Search

Your search keyword '"Hannema SE"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Hannema SE" Remove constraint Author: "Hannema SE"
98 results on '"Hannema SE"'

Search Results

2. Gonadectomy in conditions affecting sex development

3. Real-World Estimates of Adrenal Insufficiency-Related Adverse Events in Children With Congenital Adrenal Hyperplasia

4. Under-reported aspects of diagnosis and treatment addressed in the Dutch-Flemish guideline for comprehensive diagnostics in disorders/differences of sex development

5. Bone development in transgender adolescents treated with gnrh analogues and subsequent gender-affirming hormones

6. Late Endocrine Effects After HSCT in Children With Nonmalignant Diseases; A Single Center Cohort Analysis

7. SUN-080 We Mind Your Step: Understanding and Preventing Drop-Out in the Transition from Paediatric to Adult Tertiary Endocrine Healthcare

8. Disorders of Sex Development

9. Use of Fertility Preservation Among a Cohort of Transgirls in the Netherlands

10. IGF-1 and IGF-1 SDS - Fit for purpose?

11. MANAGEMENT OF ENDOCRINE DISEASE Approach to the management of children and adolescents with Gender Dysphoria

12. Changes in Adrenal Androgens During Puberty Suppression and Gender-Affirming Hormone Treatment in Adolescents With Gender Dysphoria

14. Birth weight in different etiologies of disorders of sex development

15. Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood

18. Temporal Trends in Acute Adrenal Insufficiency Events in Children With Congenital Adrenal Hyperplasia During 2019-2022.

19. Variations in volume; Breast size in trans women in relation to timing of testosterone suppression.

20. Shaping the skeleton: impact of GnRH analogue and sex hormone therapy on skeletal dimensions in transgender individuals.

21. Time Course of Body Composition Changes in Transgender Adolescents During Puberty Suppression and Sex Hormone Treatment.

22. Genome-wide methylation analysis in patients with proximal hypospadias - a pilot study and review of the literature.

23. Effects and Safety of Growth Hormone Treatment in Six Children with Pycnodysostosis.

25. A European Network for the Investigation of Gender Incongruence in adolescents.

26. Spleen function is reduced in individuals with NR5A1 variants with or without a difference of sex development: a cross-sectional study.

27. Androgen Excess and Deficiency: Analytical and Diagnostic Approaches.

28. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.

29. Medical decision-making competence regarding puberty suppression: perceptions of transgender adolescents, their parents and clinicians.

31. The dose-dependent effect of estrogen on bone mineral density in trans girls.

32. Effect of Busulfan and Treosulfan on Gonadal Function after Allogeneic Stem Cell Transplantation in Children and Adolescents with Nonmalignant Diseases Is Not Exposure-Dependent.

33. Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis.

34. [Children and adolescents with gender questions: dilemmas in the hormonal treatment by multidisciplinary teams].

35. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.

36. Prenatal ultrasound finding of atypical genitalia: Counseling, genetic testing and outcomes.

38. Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys.

39. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.

40. Mobile Phone Applications Voice Tools and Voice Pitch Analyzer Validated With LingWAVES to Measure Voice Frequency.

41. Improved growth with growth hormone treatment in children after hematopoietic stem cell transplantation.

42. Late endocrine effects after hematopoietic stem cell transplantation in children with nonmalignant diseases.

43. We mind your step: understanding and preventing drop-out in the transfer from paediatric to adult tertiary endocrine healthcare.

44. Treatment of congenital adrenal hyperplasia in children aged 0-3 years: a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure.

45. Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.

46. Growth, puberty and testicular function in boys born small for gestational age with a nonspecific disorder of sex development.

47. Histological study on the influence of puberty suppression and hormonal treatment on developing germ cells in transgender women.

48. Perceptions on the function of puberty suppression of transgender adolescents who continued or discontinued treatment, their parents, and clinicians.

49. Second-tier Testing for 21-Hydroxylase Deficiency in the Netherlands: A Newborn Screening Pilot Study.

50. Gonadectomy in conditions affecting sex development: a registry-based cohort study.

Catalog

Books, media, physical & digital resources